Blog
Did Beyond Meat Stock Just Turn a Corner?
Beyond Meat (NASDAQ: BYND) has been struggling mightily amid inflation. Shares of the fake-meat company plunged 81% last year because its growth was nonexistent and profitability looked like nothing
These 2 Stocks Have Plenty of Room to Run
It's always fun to catch a rising star on the way up. If the star happens to be the stock of a successful company, you're also looking at a profitable experience over time.
That's what I see in
The Best Stocks to Invest $20,000 in Right Now
Investing your hard-earned money can be daunting, and those picking stocks know how much time and effort can go into such an endeavor. However, over the long term, investing in the stock market is
AI Revolution on the Horizon: 2 High-Potential Growth Stocks to Watch in 2023
Artificial intelligence (AI) is all the rage these days, and given how rapidly the field is advancing, it's probably going to keep being the rage for quite some time -- potentially forever, if the
With Bookings at Historical Levels, Norwegian Cruise Line Stock Is Worth a Closer Look
After record-breaking bookings in recent months, Norwegian Cruise Line Holdings (NYSE: NCLH) looks to be rebounding from its pandemic-era slump. No doubt, numerous headwinds persist as the company
Where Will Walmart Stock Be in 3 Years?
Renowned retailer Walmart (NYSE: WMT) doesn't need much introduction; it's the largest retailer in the world when ranked by revenue, and it has stores located within 10 miles of 90% of Americans
2 Top Stocks to Buy in March and Hold Forever
If you're looking for more great stocks to add to your portfolio this month, you don't have to look far to find quality businesses with compelling growth stories. Provided you have the capital on
A Bull Market Is Coming: 2 Reasons to Buy Amazon Stock Before It's Too Late
The 2022 bear market was brutal. The Nasdaq Composite Index ended last year down by about 33%. However, it has been recovering nicely in 2023: For the last 12 months, it's now down just 9.6%. Amazon
Better Buy: Amazon Stock vs. Disney Stock
After soaring to 9.1% in June 2022, the inflation rate eased to a still-high 6.4% this past January. This steep rise in the cost of living has led to a challenging year for all kinds of industries
Toronto-Dominion Bank Stock Is Still on Sale. Is It Right for You?
While the Great Recession was leading to dividend cuts at dominant U.S. banks like Citi and Bank of America, Toronto-Dominion Bank (NYSE: TD) held its dividend steady. That's a testament to TD
Pfizer Is Targeting an Acquisition That Could Be a Game Changer for Its Business
A big challenge for healthcare giant Pfizer (NYSE: PFE) is going to be replacing revenue from its COVID-19 vaccine this year and beyond. While it has a strong pipeline that can potentially help
These 2 Stocks Cuddled Up to Investors Thursday Morning
The stock market remained in a tug-of-war between bulls and bears early Thursday. Investors are confused about the likely course of monetary policy going forward and the potential economic impact of
If I Could Only Buy 1 Stock Right Now, This Would Be It
It's not easy buying when everyone else is selling, but Wall Street wisdom suggests that's exactly what long-term investors should be doing. My take on that is to focus on long-term dividend payers
These 3 Meme Stocks Have Legitimate Long-Term Upside
Many conversations regarding "meme stocks" revolve around GameStop, AMC Entertainment, or other struggling companies. That's because those stocks were volatile, heavily shorted, and ripe for short
3 Top Pot Stocks to Buy Right Now
Investors in cannabis companies should know they're playing a long game. That's because marijuana sales will continue to rise as more states legalize cannabis over the next few years. And
Airbnb Is Down 41% From Its High. Time to Buy?
Airbnb (NASDAQ: ABNB) is a bona fide travel stock superstar thus far in 2023. It's not only trouncing the performance of the S&P 500 index but also sailing past fellow travel titans Expedia and
2 No-Brainer Warren Buffett Stocks to Buy Right Now
Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett is a legend within investing circles, and for good reason. Over the past 57 years, Berkshire has delivered a compound annual return
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
Dividend stocks offer something for every type of investor. Whether you're risk-averse or prefer a more aggressive style of putting your cash to work in the market, companies with a lengthy track
2 Soaring Stocks I'd Buy Now With No Hesitation
Since the start of 2023, multiple stocks across various industries have been on the rise. After a sell-off last year, signs of a recovery are encouraging for the market's future. As a result, now is
Here's How Aurora Cannabis Finally Posted an Adjusted EBITDA Profit
Aurora Cannabis (NASDAQ: ACB) hit a long-awaited milestone in its most recent earnings results: adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) profitability. It's
2 Explosive Stocks That Could Go Parabolic
Even as the volatile market continues to deliver highs and lows to investors, that doesn't mean you can't continue to work toward your long-term personal portfolio goals. The types of companies you
Want $1 Million in Retirement? Invest $200,000 in These 3 Stocks and Wait a Decade
Generating 5x returns over a decade is no simple feat. However, $200,000 invested evenly across a basket of The Trade Desk (NASDAQ: TTD), Pubmatic (NASDAQ: PUBM), and Global-e Online (NASDAQ: GLBE)
1 Trend for Cannabis Investors to Watch for in 2023
The cannabis industry in Canada hasn't been in good shape for some time. Growth is almost nonexistent, profits are elusive, and stock prices of marijuana producers have been nosediving. What's
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are up more than 19% over the past 12 months during a period in which many other gene-editing biotech stocks tumbled.
It's easy to see why investors
Is It Too Late to Buy Moderna Stock?
Moderna (NASDAQ: MRNA) was the star of 2020 and 2021, with its shares skyrocketing as a result of its ambitious work to develop a coronavirus vaccine and get it approved for sale. Since March 2020


